Cerus Corp. Stock
Pros and Cons of Cerus Corp. in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cerus Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cerus Corp. | 1.820% | 29.480% | 38.528% | 92.937% | 27.854% | 8.004% | -54.656% |
| SI-BONE Inc | -0.900% | 4.762% | -2.655% | -26.667% | -34.911% | - | - |
| Lantheus Holdings Inc | 5.450% | 7.479% | 17.540% | 9.111% | 35.664% | -9.133% | - |
| Lemaitre Vascular Inc | -2.660% | -1.604% | -3.665% | 28.671% | 30.496% | - | - |
Comments
Cerus (NASDAQ:CERS) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $4.00 price target on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its price target lowered by analysts at Stifel Nicolaus from $6.00 to $3.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CERS provided by MarketBeat
